Reducing the Nicotine Content of Cigarettes and the Tobacco Endgame

Duration
60 Minutes
Speakers

Neal L. Benowitz, MD

Emeritus Professor of Medicine and Bioengineering & Therapeutic Sciences, University of California, San Francisco

Neal L. Benowitz, MD, is Emeritus Professor of Medicine and Bioengineering & Therapeutic Sciences at the University of California, San Francisco (UCSF). He was Chief of the Division of Clinical Pharmacology and Experimental Therapeutics at UCSF for 35 years. He received his medical degree from the University of Rochester School of Medicine in 1969, following which he served as a resident in internal medicine at the Bronx Municipal Hospital Center from 1969 to 1971. He then completed a postdoctoral fellowship in clinical pharmacology at UCSF and joined the faculty in 1974. His research interests have focused primarily on the human pharmacology and toxicology of nicotine. He has published more than 700 research papers. Dr Benowitz maintains an active clinical practice in cardiovascular medicine and medical toxicology.

Dr Benowitz was a scientific editor of the 1988 United States Surgeon General’s Report on Smoking and Health: Nicotine Addiction; a scientific editor of the 2001 NCI Monograph 13 Report on Risks Associated with Smoking Cigarettes with Low Machine-Measured Yields of Tar and Nicotine; and served as section editor for the 2010 Surgeon General’s Report on How Tobacco Smoke Causes Disease. He, has served as a member of the National Institutes of Health Pharmacology Study Section and the FDA Nonprescription Drug and Tobacco Products Science Advisory Committees. He has served as President of the American Society for Clinical Pharmacology and Therapeutics and as President of the Society for Research on Nicotine and Tobacco. Dr Benowitz has received the Ove Ferno, Alton Ochsner, and Rawls-Palmer Progress in Medicine awards, and the Oscar B. Hunter Memorial Award in Therapeutics for his research on nicotine, tobacco, and health, and was the 2002 UCSF Annual Distinguished Clinical Research Lecturer.

Webinar Objectives
  1. Describe the impact of a nicotine reduction strategy with respect to tobacco control
  2. Develop public messaging with respect to the reasons for nicotine reduction
  3. Describe the potential impact of nicotine reduction on smoking cessation programs
Instructions for CME/CE Credit

CME/CE credit is no longer available for this activity. The CME/CE credit has expired.

 

Certificates of Attendance

Click here to generate a certificate of attendance for participating on this webinar.

 

Additional Resources Cited in the Webinar